Related Experiment Video
Updated: Feb 19, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Timeliness of Care for Transferred and Directly Admitted Patients With Anticoagulation-Associated Intracerebral
Regina Royan1,2,3, Jeffrey L Saver4, Nicole Solomon5
1Department of Emergency Medicine University of Michigan Ann Arbor MI USA.
Background:
Patients with anticoagulation-associated intracerebral hemorrhage are often transferred from the presenting hospital to one with additional resources. Understanding differences in timeliness and care, including anticoagulant reversal, between transfer and direct admissions may identify quality improvement opportunities.
Methods:
This cross-sectional study included all hospitals in the American Heart Association GWTG-Stroke (Get With The Guidelines-Stroke) registry where anticoagulant reversal was administered (2015-2021). Patients with anticoagulation-associated intracerebral hemorrhage presenting within 24 hours of onset and with information on prior AC treatment were included. Outcomes included functional score at discharge, in-hospital death/discharge to hospice, discharge ambulatory status, discharge destination, and length of stay.
Results:
Of 30 590 patients with AC-ICH, 14 882 (48.6%) were transfers. Symptom onset to AC reversal was longer for transfer patients who received anticoagulant reversal at the admitting hospital versus direct-admission patients (512 [interquartile range 328-840] versus 273 [interquartile range, 153-579] minutes; absolute standardized mean difference, 75.9%). Transfer patients had milder stroke severity on admission versus direct-admission patients on the basis of National Institute of Health Stroke Scale (7 [interquartile range, 2-19] versus 11 [interquartile range, 3-22]; absolute standardized mean difference, 21.2%) and intracerebral hemorrhage scores (1.81±1.36 versus 2.02±1.47; absolute standardized mean difference, 13.7%). In an adjusted logistic regression model, transfer patients had lower odds of in-hospital death/discharge to hospice (adjusted odds ratio, 0.78 [95% CI, 0.72-0.85]), but no difference in discharge functional score, ambulatory status, or discharge home versus direct-admission patients.
Conclusions:
Transfer patients with anticoagulation-associated intracerebral hemorrhage had longer times to reversal at the admitting hospital, less severe intracerebral hemorrhage, and lower odds of in-hospital death versus direct-admission patients after adjustment.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Acute Coronary Syndrome IV: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

